Co-Authors
This is a "connection" page, showing publications co-authored by Florence Ader and Florent Wallet.
Connection Strength
0.518
-
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-ß-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec; 27(12):1826-1837.
Score: 0.237
-
Immune monitoring of interleukin-7 compassionate use in a critically ill COVID-19 patient. Cell Mol Immunol. 2020 09; 17(9):1001-1003.
Score: 0.224
-
Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19). Med Mycol. 2021 Jan 04; 59(1):110-114.
Score: 0.058